174 related articles for article (PubMed ID: 12406656)
1. CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo.
Li F; Zhang X; Mizzi C; Gordon JR
Vet Immunol Immunopathol; 2002 Nov; 90(1-2):65-77. PubMed ID: 12406656
[TBL] [Abstract][Full Text] [Related]
2. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
3. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
4. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
[TBL] [Abstract][Full Text] [Related]
5. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
[TBL] [Abstract][Full Text] [Related]
6. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of pathology by ELR-CXC chemokine antagonism in a swine model of airway endotoxin exposure.
Gordon JR; Zhang X; Li F; Nayyar A; Town J; Zhao X
J Agromedicine; 2009; 14(2):235-41. PubMed ID: 19437283
[TBL] [Abstract][Full Text] [Related]
8. CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice.
Schneberger D; Gordon JR; DeVasure JM; Boten JA; Heires AJ; Romberger DJ; Wyatt TA
Pulm Pharmacol Ther; 2015 Apr; 31():55-62. PubMed ID: 25681618
[TBL] [Abstract][Full Text] [Related]
9. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
10. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury.
Zhao X; Town JR; Yang A; Zhang X; Paur N; Sawicki G; Gordon JR
J Surg Res; 2010 Aug; 162(2):264-73. PubMed ID: 19691980
[TBL] [Abstract][Full Text] [Related]
11. A new protocol for high-yield purification of recombinant human CXCL8((3-72))K11R/G31P expressed in Escherichia coli.
Cheng HT; Huang KC; Yu HY; Gao KJ; Zhao X; Li F; Town J; Gordon JR; Cheng JW
Protein Expr Purif; 2008 Sep; 61(1):65-72. PubMed ID: 18541440
[TBL] [Abstract][Full Text] [Related]
12. CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose-Induced Mesangial Injury.
Cui S; Zhu Y; Du J; Khan MN; Wang B; Wei J; Cheng JW; Gordon JR; Mu Y; Li F
Endocrinology; 2017 Jun; 158(6):1671-1684. PubMed ID: 28387853
[TBL] [Abstract][Full Text] [Related]
13. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
14. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy.
Ye Y; Zhang Y; Wang B; Walana W; Wei J; Gordon JR; Li F
Biomed Pharmacother; 2018 Nov; 107():1142-1150. PubMed ID: 30257327
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
16. ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke.
Connell BJ; Gordon JR; Saleh TM
Neurosci Lett; 2015 Oct; 606():117-22. PubMed ID: 26320021
[TBL] [Abstract][Full Text] [Related]
17. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.
Walana W; Ye Y; Li M; Wang J; Wang B; Cheng JW; Gordon JR; Li F
Biomed Pharmacother; 2018 Jul; 103():253-261. PubMed ID: 29655167
[TBL] [Abstract][Full Text] [Related]
18. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
20. Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowth.
Zhao X; Town JR; Li F; Li W; Zhang X; Gordon JR
Pulm Pharmacol Ther; 2010 Feb; 23(1):22-8. PubMed ID: 19751843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
